TINOS THERAPEUTICS Trademark

Trademark Overview


On Monday, May 1, 2023, a trademark application was filed for TINOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TINOS THERAPEUTICS trademark a serial number of 97914745. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, March 10, 2025. This trademark is owned by Tinos Therapeutics, Inc.. The TINOS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)
tinos therapeutics

General Information


Serial Number97914745
Word MarkTINOS THERAPEUTICS
Filing DateMonday, May 1, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, March 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and Servicespharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)
NOT AVAILABLE"THERAPEUTICS"
Translation of Words in MarkThe wording TINOS has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTinos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBarrington, RI 02806

Party NameTinos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBarrington, RI 02806

Trademark Events


Event DateEvent Description
Thursday, May 4, 2023NEW APPLICATION ENTERED
Tuesday, May 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 26, 2024ASSIGNED TO EXAMINER
Wednesday, April 24, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, July 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 7, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 10, 2025SOU EXTENSION 1 FILED
Monday, March 10, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT